Clasp Therapeutics is making waves in the field of immuno-oncology with its groundbreaking approach to creating next-generation T cell engagers (TCEs) that target tumor-specific oncogenic driver mutations. The company has successfully raised an impressive $150 million in a recent funding round, a testament to the confidence investors have in its innovative platform. This substantial investment reflects Clasp’s commitment to developing personalized, off-the-shelf therapeutics that cater to the unique genetic makeup of patients' tumors and the specific characteristics of their immune systems, particularly for hard-to-treat cancers that have long posed challenges in effective treatment. Founded in March 2024 and based in Cambridge, MA, and Rockville, MD, Clasp is built on pioneering research from renowned experts Bert Vogelstein and Drew Pardoll at Johns Hopkins University. The funding will empower Clasp to accelerate its research and development efforts, driving forward its mission to revolutionize cancer treatment through precision medicine. With backing from notable life sciences investors including Catalio Capital Management, Third Rock Ventures, and Novo Holdings, Clasp is poised to make a significant impact in the oncology landscape. By integrating state-of-the-art science with patient-centric approaches, Clasp Therapeutics aims not only to enhance the efficacy of cancer treatments but also to bring hope to patients battling with some of the most challenging cancers today. To learn more about the company and its groundbreaking work, please visit www.clasptx.com.
Revolutionizing Immuno-Oncology: Clasp Therapeutics Secures $150M in Series A Funding
Get the full Clasp Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Equal
India’s largest consent-based data-sharing and verification platform. At Equal, we believe access should be built on trust. We enable organisations to verify, onboard, and engage individuals faster through secure, real-time, consented data. Powering high-impact employment and financial journeys across India. ✓ Employment & HR Technology - From background verification to onboarding, we help businesses hire with confidence and speed. Our solutions span KYC, BGV, employment verification, and HR tech workflows - reducing turnaround times, accelerating offer rollouts, and enabling seamless, fully digital candidate verification. With easy HRMS integrations, we make onboarding smoother, faster, and more efficient end to end. ✓ BFSI & Open Finance Infrastructure - We enable seamless, consent-driven financial data access through the Account Aggregator ecosystem. With our TSP solution, MoneyOne, and our partnership with OneMoney - India’s first and largest RBI-licensed Account Aggregator - we help financial institutions access and utilise data faster and more securely, powering reliable and trustworthy financial journeys across lending, FnO, insurance, and more. Equal powers trust. Equal powers India. ??
$30.0M Series b
today
Chatsee
Share anonymously with strangers & make new friends with Chatsee for iOS https://chats.ee/download/
$6.5M Seed
today
Sybilla Technologies
Sybilla Technologies designs, builds, and operates robotic optical observatories for monitoring objects in space. Company specializes in the software for automated data acquisition, analysis and scheduling of networks of sensors, as well as designing and building turnkey observatories. We work in the domains of Space Situational Awareness, Space Surveillance and Tracking, Space Traffic Management, Near Earth Objects, stellar and planetary research, education, and commercial on-demand observations.
$9.3M Seed
today
esVolta, LP
Focused on sustainability and innovation, esVolta develops, owns, and operates reliable utility-scale energy storage assets across the entire lifecycle - delivering value for utilities, energy users, and investors.
$450.0M Unknown
today
Sleek
✅ Built by entrepreneurs, for entrepreneurs, Sleek’s mission is to make the lives of our fellow entrepreneurs easier. ? It is the easiest way to get started and manage a business day to day. Just one platform to digitally manage company incorporation, compliance, bookkeeping & accounting, payroll, reporting, taxes and SO much more. Sleek's human-first, tech-enabled approach helps entrepreneurs automate repetitive tasks, while our supportive experts offer the best, personalised advice to our customers. ? Present across Singapore, UK, Australia and Hong Kong, Sleek has served over 450,000 clients across 110 countries, and processed millions of bookkeeping transactions digitally. ? Sleek is registered with the company registry and tax authorities of Singapore, Hong Kong, Australia and the UK. We are also regulated by the Monetary Authority of Singapore under the Payment Services Act, and issued a Major Payment Institution (MPI) licence No. PS20200521.
$9.0M Series a
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Sleek Singapore | Series a | $9.0M | today |
| 2 |  Manam Chocolate | Series a | $9.0M | today |
| 3 |  Aryon Security | Series a | $25.0M | today |
| 4 |  Mendo France | Series a | $13.6M | today |
| 5 |  Neion Bio United States | Series a | $23.0M | today |